Minneapolis-based life settlements specialist GWG Life claims it is the first insuretech company to apply “epigenetic technology” in a way that it says could transform life insurance underwriting (link below).
Saliva samples are being used to analyze the overall health and life expectancy of policy owners. The samples contain cells that can be analyzed for specific levels of methylation that occur in epigenetic biomarkers which are said to be predictive of an individual’s risk of all-cause mortality.
This would contribute to a more accurate estimate of the life expectancy of policyholder
Source of insurance-forums.net
Saliva samples are being used to analyze the overall health and life expectancy of policy owners. The samples contain cells that can be analyzed for specific levels of methylation that occur in epigenetic biomarkers which are said to be predictive of an individual’s risk of all-cause mortality.
This would contribute to a more accurate estimate of the life expectancy of policyholder
Comments
Post a Comment